Natco Pharma Ltd.
BSE: 524816 | Sector: Health care |
NSE: NATCOPHARM | ISIN Code: INE987B01026 |
BSE 09:39 | 04 Jul | 649.35 |
-1.35 (-0.21%) |
OPEN
662.00 |
HIGH
662.00 |
LOW
648.60 |
NSE 09:29 | 04 Jul | 650.15 |
-0.25 (-0.04%) |
OPEN
655.00 |
HIGH
657.80 |
LOW
649.50 |
OPEN | 662.00 |
PREVIOUS CLOSE | 650.70 |
VOLUME | 1090 |
52-Week high | 1188.05 |
52-Week low | 607.95 |
P/E | 85.22 |
Mkt Cap.(Rs cr) | 11,854 |
Buy Price | 649.10 |
Buy Qty | 21.00 |
Sell Price | 650.15 |
Sell Qty | 20.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Natco Pharma Ltd. (NATCOPHARM) - Nine Monthly Result
Particulars (![]() |
Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 |
Net Sales/Income From Operations | 1253.70 | 1342.00 | 1370.10 | 1570.00 | 1362.30 |
Other Income | 84.20 | 72.00 | 85.20 | 99.10 | 18.80 |
Total Income | 1337.90 | 1414.00 | 1455.30 | 1669.10 | 1381.10 |
Total Expenditure | 1003.00 | 1000.80 | 910.70 | 903.70 | 810.20 |
Operating Profit | 334.90 | 413.20 | 544.60 | 765.40 | 570.90 |
Interest | 9.10 | 9.00 | 17.10 | 13.60 | 12.00 |
Gross Profit | 325.80 | 404.20 | 527.50 | 751.80 | 558.90 |
Depreciation | 102.80 | 85.40 | 68.30 | 58.80 | 47.70 |
PBT | 223.00 | 318.80 | 459.20 | 693.00 | 511.20 |
Tax | 39.70 | 69.00 | 103.50 | 170.30 | 109.10 |
Net Profit/(Loss) | 200.40 | 252.30 | 373.50 | 543.70 | 402.10 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 200.40 | 252.30 | 373.50 | 543.70 | 402.10 |
Equity Share Capital | 36.50 | 36.40 | 36.40 | 36.80 | 36.90 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 10.99 | 13.85 | 20.53 | 29.47 | 22.94 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Natco Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices